REPL PE Ratio & Valuation,Is REPL Overvalued

REPL Relative Valuation

REPL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, REPL is overvalued; if below, it's undervalued.

Historical Valuation

Replimune Group Inc (REPL) is now in the Fair zone, suggesting that its current forward PS ratio of 22.61 is considered Fairly compared with the five-year average of -7.10. The fair price of Replimune Group Inc (REPL) is between -- to -- according to relative valuation methord.

Relative Value

Fair Zone

-----

Current Price：9.94

Fair

-3.50

0.00

EV/EBITDA

Replimune Group Inc. (REPL) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is -2.82. The thresholds are as follows: Strongly Undervalued below -11.60, Undervalued between -11.60 and -7.21, Fairly Valued between 1.56 and -7.21, Overvalued between 1.56 and 5.95, and Strongly Overvalued above 5.95. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.

-2.00

EV/EBIT

Replimune Group Inc. (REPL) has a current EV/EBIT of -2.00. The 5-year average EV/EBIT is -3.79. The thresholds are as follows: Strongly Undervalued below -11.86, Undervalued between -11.86 and -7.83, Fairly Valued between 0.24 and -7.83, Overvalued between 0.24 and 4.27, and Strongly Overvalued above 4.27. The current Forward EV/EBIT of -2.00 falls within the Historic Trend Line -Fairly Valued range.

22.61

Replimune Group Inc. (REPL) has a current PS of 22.61. The 5-year average PS is 7.69. The thresholds are as follows: Strongly Undervalued below -42.90, Undervalued between -42.90 and -17.61, Fairly Valued between 32.98 and -17.61, Overvalued between 32.98 and 58.28, and Strongly Overvalued above 58.28. The current Forward PS of 22.61 falls within the Historic Trend Line -Fairly Valued range.

-4.52

P/OCF

Replimune Group Inc. (REPL) has a current P/OCF of -4.52. The 5-year average P/OCF is -7.81. The thresholds are as follows: Strongly Undervalued below -20.01, Undervalued between -20.01 and -13.91, Fairly Valued between -1.71 and -13.91, Overvalued between -1.71 and 4.39, and Strongly Overvalued above 4.39. The current Forward P/OCF of -4.52 falls within the Historic Trend Line -Fairly Valued range.

-3.53

P/FCF

Replimune Group Inc. (REPL) has a current P/FCF of -3.53. The 5-year average P/FCF is -7.55. The thresholds are as follows: Strongly Undervalued below -19.15, Undervalued between -19.15 and -13.35, Fairly Valued between -1.74 and -13.35, Overvalued between -1.74 and 4.06, and Strongly Overvalued above 4.06. The current Forward P/FCF of -3.53 falls within the Historic Trend Line -Fairly Valued range.

Replimune Group Inc (REPL) has a current Price-to-Book (P/B) ratio of 3.03. Compared to its 3-year average P/B ratio of 1.81 , the current P/B ratio is approximately 67.80% higher. Relative to its 5-year average P/B ratio of 2.20, the current P/B ratio is about 37.87% higher. Replimune Group Inc (REPL) has a Forward Free Cash Flow (FCF) yield of approximately -33.77%. Compared to its 3-year average FCF yield of -27.82%, the current FCF yield is approximately 21.42% lower. Relative to its 5-year average FCF yield of -19.47% , the current FCF yield is about 73.46% lower.

2.96

P/B

Median3y

1.81

Median5y

2.20

-33.77

FCF Yield

Median3y

-27.82

Median5y

-19.47

Competitors Valuation Multiple

The average P/S ratio for REPL's competitors is 0.00, providing a benchmark for relative valuation. Replimune Group Inc Corp (REPL) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of REPL increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of REPL in the past 1 year is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is Replimune Group Inc (REPL) currently overvalued or undervalued?

What is Replimune Group Inc (REPL) fair value?

REPL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Replimune Group Inc (REPL) is between to according to relative valuation methord.

How does REPL's valuation metrics compare to the industry average?

What is the current P/B ratio for Replimune Group Inc (REPL) as of Dec 16 2025?

As of Dec 16 2025, Replimune Group Inc (REPL) has a P/B ratio of 3.03. This indicates that the market values REPL at 3.03 times its book value.

What is the current FCF Yield for Replimune Group Inc (REPL) as of Dec 16 2025?

As of Dec 16 2025, Replimune Group Inc (REPL) has a FCF Yield of -33.77%. This means that for every dollar of Replimune Group Inc’s market capitalization, the company generates -33.77 cents in free cash flow.

What is the current Forward P/E ratio for Replimune Group Inc (REPL) as of Dec 16 2025?

As of Dec 16 2025, Replimune Group Inc (REPL) has a Forward P/E ratio of -3.58. This means the market is willing to pay $-3.58 for every dollar of Replimune Group Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Replimune Group Inc (REPL) as of Dec 16 2025?

As of Dec 16 2025, Replimune Group Inc (REPL) has a Forward P/S ratio of 22.61. This means the market is valuing REPL at $22.61 for every dollar of expected revenue over the next 12 months.

REPL Valuation